Clinical trial
Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study
NCT04327232 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study
- Lead sponsor
- National University Hospital, Singapore
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 23, 2018
- Completion date
- May 31, 2022
- Enrollment
- 184 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.